Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-022466
Filing Date
2022-08-11
Accepted
2022-08-11 16:12:13
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q blcm-20220630.htm   iXBRL 10-Q 1242689
2 EX-10.1 exhibit101directorcompensa.htm EX-10.1 20599
3 EX-31.1 a2022q2exhibit311.htm EX-31.1 11804
4 EX-32.1 a2022q2exhibit321.htm EX-32.1 6011
  Complete submission text file 0001628280-22-022466.txt   4898861

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20220630.xsd EX-101.SCH 35977
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20220630_cal.xml EX-101.CAL 42687
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20220630_def.xml EX-101.DEF 162528
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20220630_lab.xml EX-101.LAB 421885
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20220630_pre.xml EX-101.PRE 269740
45 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20220630_htm.xml XML 671388
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

EIN.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 221155991
SIC: 2834 Pharmaceutical Preparations